FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
MedShadow ArticlesWhat To Know About Cobenfy, First New FDA-Approved Treatment For Schizophrenia in DecadesJessica DiGiacinto
MedShadow ArticlesWhat’s Really Inside Your OTC Drugs? We Don’t Actually Know, And Here’s WhyEmma Yasinski
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: New Liver Injury Warnings for MS Drugs and Epilepsy TreatmentKatie Rowley
Celebrity Medical ConditionsAuthorities Investigate Matthew Perry’s Ketamine-Induced DeathMelissa Finley
MedShadow ArticlesINVESTIGATING GENERICS: Healthcare Providers Call Out Issues With Generic ADHD MedsEmma Yasinski
MedShadow ArticlesInside the FDA Drug Development Process: The Limits of Clinical Trials in Preventing Side EffectsDaphne Berryhill
